Tech-Enabled Healthcare Performance Company, 40-Year Advisory & SaaS Firm

$3.9M

Revenue

$1.5M

SDE

Subscribe Free

Read the full deal writeup

Get Free Access Access Unlimited Deals

Already a member? Sign in

Full Editorial Writeup

This is a healthcare performance-improvement firm that blends consulting, implementation services, and a digital SaaS learning platform to help hospitals, health systems, community health centers, and clinic networks improve patient experience, workforce retention, and leadership effectiveness. The delivery model is intentionally layered: advisory relationships open the door, implementation work embeds the firm into the client, and the proprietary digital library plus AI-enabled tools create a recurring, scalable product that can be deployed across large provider networks. Roughly four decades of operating history gives it credibility in a market where trust and references drive buying decisions.

The company does about $3.9 million in revenue at a roughly 22.6% EBITDA margin, which translates to the disclosed $1.53 million in cash flow. One hundred percent of revenue is domestic, and management emphasizes long-term engagements, repeat business, and recurring revenue. An owned annual healthcare industry conference functions as a built-in demand-generation and retention engine, which is a meaningful and hard-to-replicate asset in a relationship-driven vertical.

The founder is running a confidential, planned succession process through ProNova Partners, with the business name withheld until a buyer signs an NDA and is vetted. The pitch is a differentiated, sticky platform positioned for a buyer who can push scale, sales infrastructure, and productization of the existing proprietary content library.

Why we like it

Earnings quality looks solid with $1.53M of cash flow on $3.9M of revenue, a clean 22.6% EBITDA margin that is healthy for a blended services-plus-software model. The 100% US revenue base removes FX and offshore client-concentration risk, and the margin suggests the SaaS and content layers are carrying real leverage rather than the business being pure bodies-for-hire consulting.
Durability is anchored by four decades of operating history and long-term client engagements that produce repeat business and recurring revenue. Healthcare systems are slow to switch vendors once embedded, and the proprietary library of education, leadership, and patient-experience content plus an owned annual industry conference create switching costs and a referral moat that a new entrant cannot buy.
Market tailwinds are real: hospitals and health systems face persistent staffing shortages, nurse burnout, and reimbursement tied to patient-experience scores (HCAHPS), so workforce engagement and performance improvement are budgeted spend, not nice-to-haves. This is counter-cyclical demand because labor and retention problems intensify, not shrink, in tough times.
Operator advantage is unusually clear here. The business has a founder-run sales motion and an underexploited content library plus conference, meaning a buyer with real sales infrastructure and a productization playbook can grow this without reinventing the product. The recurring digital layer gives you a lever consulting-only firms lack.

How to improve it

Productize the proprietary content library into tiered, per-seat SaaS subscriptions sold across entire health systems rather than one-off advisory engagements. Shifting revenue mix toward high-margin recurring software would lift the exit multiple and smooth the cash flow that today likely lumps around project timing.
Build a repeatable sales and account-management function to replace founder-led business development. The listing signals the founder is central to relationships, so hiring and systematizing a small enterprise sales team in the first year de-risks the asset and unlocks the embedded conference as a top-of-funnel engine.
Monetize the annual conference far more aggressively through sponsorships, higher ticket tiers, year-round virtual programming, and structured lead capture that feeds the sales pipeline. An owned event in a relationship-driven vertical is underleveraged if it only runs once a year.
Lean into the AI-enabled capabilities mentioned in the listing by packaging them as a differentiated, named product with clear ROI metrics (retention lift, HCAHPS improvement). Clear, measurable outcomes shorten sales cycles and justify premium pricing in healthcare buying.
Expand net revenue retention by cross-selling the implementation services, SaaS learning, and advisory layers into existing accounts. Mapping each large client to the full product stack is the fastest, cheapest growth lever before chasing new logos.
Pursue adjacent buyer segments beyond hospitals, specifically community health centers and large physician and clinic networks that face the same retention and patient-experience pressures. The content and tools are largely transferable, so incremental TAM expansion requires marketing more than new product.

Diligence notes

Confirm the actual split between recurring SaaS/subscription revenue and project-based advisory or implementation fees. The listing uses 'recurring revenue' loosely, and the valuation hinges entirely on how much is contracted and renewing versus re-won each year.
Quantify founder dependency: how many client relationships, sales, and renewals run through the founder personally. A planned retirement is positive, but if the founder is the brand and the rainmaker, the transition risk and required earnout structure change materially.
Examine client concentration and contract terms, including the length, renewal history, and churn of the long-term engagements. In a sub-$4M revenue firm, a handful of large hospital clients could represent outsized risk if any are on short or at-will terms.
Validate the economics and ownership of the annual conference, including whether it is profitable on its own and whether the venue, sponsor, and attendee relationships transfer cleanly. If it is loss-making or founder-driven, the 'embedded growth engine' narrative needs discounting.
Verify the EBITDA margin and cash flow add-backs given the blended model, since consulting labor costs and conference expenses can be lumpy. Normalize for any founder compensation, personal expenses, and one-time items to get a true buyer-side earnings number before pricing the deal.

Source

Originally listed on BusinessBroker.net. View original listing →